Displaying 901–908 of 908 results
Mar 19, 2012
When it comes to describing Eric Fulton, “gregarious” is a more-than-appropriate adjective for the husband and father of two who, fittingly, is also communications manager at the Bethesda-based Clark Construction Group. “It comes naturally to me,” he says of his ability to mix it up with people. “The cause makes it easier. But, otherwise, I’m pretty outgoing; I like to talk to people. It’s what I do.”
Mar 2, 2012
MitoChem Therapeutics has identified three compounds that appear to boost mitochondrial function and, thus, show potential for slowing vision loss caused by a variety of retinal degenerations.
Feb 9, 2012
What you need to know (and what to expect) about clinical trials.
Oct 4, 2011
A Foundation-funded research group is developing a gene therapy that revives degenerating cones, enabling them to regain their ability to respond to light and provide vision.
Apr 4, 2011
A research team funded by the Foundation Fighting Blindness used an innovative repair technique to correct the disease-causing genetic defect in stem cells derived from a person’s skin — stem cells that hold the potential to treat their retinal degenerative condition.
Jan 26, 2011
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
Sep 30, 2009
Thanks to Foundation-funded researchers at the University of Wisconsin-Madison, skin cells might someday restore vision lost to retinal degenerative diseases.
May 8, 2008